Soluble HLA-G inhibits human dendritic cell-triggered allogeneic T-cell proliferation without altering dendritic differentiation and maturation processes

Human Immunology

Volumn 64, Issue 8, 2003, Pages 752-761

  Le Friec, Gaëlle ^a   Laupèze, Béatrice ^a   Fardel, Olivier ^a   Sebti, Yasmine ^a   Pangault, Céline ^a   Guilloux, Valérie ^a   Beauplet, Alain ^b   Fauchet, Renée ^a   Amiot, Laurence ^a,c  

^a UNIVERSITÉ DE RENNES 1   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

^c Lab Univ Hematol Biol Cell S   (France)

Author keywords

Apoptosis; Cellular differentiation; Dendritic cells; Soluble HLA G; T lymphocytes

Indexed keywords

CD34 ANTIGEN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 1B; HLA G ANTIGEN; HLA G5 ANTIGEN; HLA-G ANTIGEN; ILT4 ANTIGEN; SOLUBLE HLA G ANTIGEN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL MEDIATED CYTOTOXICITY; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOMODULATION; MELANOMA; METABOLISM; MIXED LYMPHOCYTE CULTURE; MIXED LYMPHOCYTE REACTION; MONOCYTE; NATURAL KILLER CELL; PHENOTYPE; PHYSIOLOGY; PRIORITY JOURNAL; SOLUBILITY; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TUMOR CELL LINE; WESTERN BLOTTING;

EID: 0042209924     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(03)00091-0     Document Type: Article

References (48)

1. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R: A class I antigen, HLA-G, expressed in human trophoblasts. Science 248:220, 1990.
2. Ishitani A, Geraghty DE: Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci USA 89:3947, 1992.
3. Kirszenbaum M, Moreau P, Gluckman E, Dausset J, Carosella E: An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci USA 91:4209, 1994.
4. Fujii T, Ishitani A, Geraghty DE: A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 153:5516, 1994.
5. Paul P, Cabestre FA, Ibrahim EC, Lefebvre S, Khalil-Daher I, Vazeux G, Quiles RM, Bermond F, Dausset J, Carosella ED: Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 61:1138, 2000.
6. Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le Gal FA, Avril MF, Dausset J, Guillet JG, Carosella ED: HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 95:4510, 1998.
7. Ibrahim EC, Guerra N, Lacombe MJ, Angevin E, Chouaib S, Carosella ED, Caignard A, Paul P: Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma. Cancer Res 61:6838, 2001.
8. Lefebvre S, Antoine M, Uzan S, McMaster M, Dausset J, Carosella ED, Paul P: Specific activation of the nonclassical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer. J Pathol 196:266, 2002.
9. Urosevic M, Kurrer MO, Kamarashev J, Mueller B, Weder W, Burg G, Stahel RA, Dummer R, Trojan A: Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol 159:817, 2001.
10. Urosevic M, Willers J, Mueller B, Kempf W, Burg G, Dummer R: HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood 99:609, 2002.
11. Wiendl H, Mitsdoerffer M, Hofmeister V, Wischhusen J, Bornemann A, Meyermann R, Weiss EH, Melms A, Weller M: A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J Immunol 168:4772, 2002.
12. Ugurel S, Rebmann V, Ferrone S, Tilgen W, Grosse-Wilde H, Reinhold U: Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy. Cancer 92:369, 2001.
13. Onno M, Le Friec G, Pangault C, Amiot L, Guilloux V, Drenou B, Caulet-Maugendre S, Andre P, Fauchet R: Modulation of HLA-G antigens expression in myelomonocytic cells. Hum Immunol 61:1086, 2000.
14. Onno M, Pangault C, Le Friec G, Guilloux V, Andre P, Fauchet R: Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 164:6426, 2000.
15. Lila N, Carpentier A, Amrein C, Khalil-Daher I, Dausset J, Carosella ED: Implication of HLA-G molecule in heart-graft acceptance. Lancet 355:2138, 2000.
16. Lila N, Amrein C, Guillemain R, Chevalier P, Latremouille C, Fabiani JN, Dausset J, Carosella ED, Carpentier A: Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 105:1949, 2002.
17. Lee N, Llano M, Carretero M, Ishitani A, Navarro F, Lopez-Botet M, Geraghty DE: HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 95:5199, 1998.
18. Llano M, Lee N, Navarro F, Garcia P, Albar JP, Geraghty DE, Lopez-Botet M: HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur J Immunol 28:2854, 1998.
19. Chumbley G, King A, Robertson K, Holmes N, Loke YW: Resistance of HLA-G and HLA-A2 transfectants to lysis by decidual NK cells. Cell Immunol 155:312, 1994.
20. Cantoni C, Verdiani S, Falco M, Pessino A, Cilli M, Conte R, Pende D, Ponte M, Mikaelsson MS, Moretta L, Biassoni R: p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamily. Eur J Immunol 28:1980, 1998.
21. Navarro F, Llano M, Bellon T, Colonna M, Geraghty DE, Lopez-Botet M: The IET2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur J Immunol 29:277, 1999.
22. Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED: The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci USA 94:5249, 1997.
23. Le Gal FA, Riteau B, Sedlik C, Khalil-Daher I, Menier C, Dausset J, Guillet JG, Carosella ED, Rouas-Freiss N: HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 11:1351, 1999.
24. Rouas-Freiss N, Khalil-Daher I, Riteau B, Menier C, Paul P, Dausset J, Carosella ED: The immunotolerance role of HLA-G. Semin Cancer Biol 9:3, 1999.
25. Riteau B, Menier C, Khalil-Daher I, Sedlik C, Dausset J, Rouas-Freiss N, Carosella ED: HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 43:203, 1999.
26. Kanai T, Fujii T, Kozuma S, Yamashita T, Miki A, Kikuchi A, Taketani Y: Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture. Mol Hum Reprod 7:195, 2001.
27. Fournel S, Aguerre-Girr M, Huc X, Lenfant F, Alam A, Toubert A, Bensussan A, Le Bouteiller P: Cutting edge: soluble HLA-G1 triggers CD95/CD95 ligand-mediated apoptosis in activated CD8+ cells by interacting with CD8. J Immunol 164:6100, 2000.
28. Spaggiari GM, Contini P, Carosio R, Arvigo M, Ghio M, Oddone D, Dondero A, Zocchi MR, Puppo F, Indiveri F, Poggi A: Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily. Blood 99:1706, 2002.
29. Spaggiari GM, Contini P, Dondero A, Carosio R, Puppo F, Indiveri F, Zocchi MR, Poggi A: Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction. Blood 100:4098, 2002.
30. Contini P, Ghio M, Poggi A, Filaci G, Indiveri F, Ferrone S, Puppo F: Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 33:125, 2003.
31. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392:245, 1998.
32. Steinman RM, Inaba K, Turley S, Pierre P, Mellman I: Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum Immunol 60:562, 1999.
33. Marchal-Bras-Goncalves R, Rouas-Freiss N, Connan F, Choppin J, Dausset J, Carosella ED, Kirszenbaum M, Guillet J: A soluble HLA-G protein that inhibits natural killer cell-mediated cytotoxicity. Transplant Proc 33:2355, 2001.
34. Colonna M, Samaridis J, Cella M, Angman L, Allen RL, O'Callaghan CA, Dunbar R, Ogg GS, Cerundolo V, Rolink A: Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol 160:3096, 1998.
35. Horuzsko A, Lenfant F, Munn DH, Mellor AL: Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol 13:385, 2001.
36. Bertho N, Drenou B, Laupeze B, Berre CL, Amiot L, Grosset JM, Fardel O, Charron D, Mooney N, Fauchet R: HLA-DR-mediated apoptosis susceptibility discriminates differentiation stages of dendritic/monocytic APC. J Immunol 164:2379, 2000.
37. Fournel S, Aguerre-Girr M, Campan A, Salauze L, Berrebi A, Lone YC, Lenfant F, Le Bouteiller P: Soluble HLA-G: purification from eukaryotic transfected cells and detection by a specific ELISA. Am J Reprod Immunol 42:22, 1999.
38. Chapuis F, Rosenzwajg M, Yagello M, Ekman M, Biberfeld P, Gluckman JC: Differentiation of human dendritic cells from monocytes in vitro. Eur J Immunol 27:431, 1997.
39. Zhou LJ, Tedder TF: CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc Natl Acad Sci USA 93:2588, 1996.
40. Laupeze B, Fardel O, Onno M, Bertho N, Drenou B, Fauchet R, Amiot L: Differential expression of major histocompatibility complex class Ia, Ib, and II molecules on monocytes-derived dendritic and macrophagic cells. Hum Immunol 60:591, 1999.
41. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED: Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci USA 94: 11520, 1997.
42. Drenou B, Blancheteau V, Burgess DH, Fauchet R, Charron DJ, Mooney NA: A caspase-independent pathway of MHC class II antigen-mediated apoptosis of human B lymphocytes. J Immunol 163:4115, 1999.
43. Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED, Carbone DP, Gabrilovich DI: Clinical significance of defective dendritic cell differentiation in cancer. Clin Cancer Res 6:1755, 2000.
44. Bertho N, Drenou B, Mooney N, Amiot L, Langanay T, Le Berre C, Charron D, Fauchet R: HLA-DR inhibits granulocytic differentiation without inducing apoptosis of CD34 cells. Hum Immunol 60:944, 1999.
45. Liang S, Baibakov B, Horuzsko A: HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor. Eur J Immunol 32:2418, 2002.
46. Pangault C, Le Friec G, Caulet-Maugendre S, Lena H, Amiot L, Guilloux V, Onno M, Fauchet R: Lung macrophages and dendritic cells express HLA-G molecules in pulmonary diseases. Hum Immunol 63:83, 2002.
47. Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED: Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci USA 98:12150, 2001.
48. Wiendl H, Mitsdoerffer M, Hofmeister V, Wischhusen J, Weiss EH, Dichgans J, Lochmuller H, Hohlfeld R, Melms A, Weller M: The non-classical MHC molecule HLA-G protects human muscle cells from immune-mediated lysis: implications for myoblast transplantation and gene therapy. Brain 126:176, 2003.